Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

O-GlcNAcylation promotes pancreatic tumor growth by regulating malate dehydrogenase 1
Qiang Zhu, Hong Zhou, Liming Wu, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 10, pp. 1087-1095
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
Qian Zhong, Xina Xiao, Yijie Qiu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 114
O -GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation
Qiang Zhu, Hongxing Wang, Siyuan Chai, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 13
Open Access | Times Cited: 67
O-GlcNAcylation in cancer development and immunotherapy
Xue-Fen He, Xiaoli Hu, Gao-Jing Wen, et al.
Cancer Letters (2023) Vol. 566, pp. 216258-216258
Closed Access | Times Cited: 41
Glycosylation: mechanisms, biological functions and clinical implications
Mengyuan He, Xiangxiang Zhou, Xin Wang
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle
Bolin Wang, Jinli Pei, Shengnan Xu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 23
The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
Qinglong Ma, Wenyang Zhang, Kongming Wu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
On a sugar high: Role of O-GlcNAcylation in cancer
Giang Lê Minh, Emily M. Esquea, Riley G. Young, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 11, pp. 105344-105344
Open Access | Times Cited: 32
KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
Zining Zhang, Heng Zhang, Xiang Liao, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 28
The role of metabolic reprogramming in pancreatic cancer chemoresistance
Chang Liu, Changfeng Li, Yuanda Liu
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 22
Role of glycosylation-related gene MGAT1 in pancreatic ductal adenocarcinoma
Lai Jiang, Jie Liu, Shengke Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Targeting O-GlcNAcylation in cancer therapeutic resistance: The sugar Saga continues
Lulu Chen, Mengxue Hu, Luojun Chen, et al.
Cancer Letters (2024) Vol. 588, pp. 216742-216742
Closed Access | Times Cited: 11
The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer
Huiru Zhang, Tianjiao Li, Xianjun Yu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 8
Direct stimulation of de novo nucleotide synthesis by O-GlcNAcylation
Lulu Chen, Qi Zhou, Pingfeng Zhang, et al.
Nature Chemical Biology (2023) Vol. 20, Iss. 1, pp. 19-29
Open Access | Times Cited: 18
Altered glycosylation in cancer: molecular functions and therapeutic potential
Xuemeng Xu, Qiu Peng, Xianjie Jiang, et al.
Cancer Communications (2024) Vol. 44, Iss. 11, pp. 1316-1336
Open Access | Times Cited: 7
Inhibition of O-GlcNAcylation Reduces Cell Viability and Autophagy and Increases Sensitivity to Chemotherapeutic Temozolomide in Glioblastoma
Amanda V. Leonel, Frederico Alisson‐Silva, Ronan Christian Santos, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4740-4740
Open Access | Times Cited: 15
circ-hnRNPU inhibits NONO-mediated c-Myc transactivation and mRNA stabilization essential for glycosylation and cancer progression
Hongjun Li, Wanju Jiao, Jiyu Song, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 13
O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation
Zhongqi Feng, Jiaxin Yin, Zhirong Zhang, et al.
Oncogene (2024) Vol. 43, Iss. 15, pp. 1149-1159
Closed Access | Times Cited: 5
The OGT–c-Myc–PDK2 axis rewires the TCA cycle and promotes colorectal tumor growth
Huijuan Wang, Jie Sun, Haofan Sun, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 9, pp. 1157-1169
Open Access | Times Cited: 5
O-GlcNAcylation in tumorigenesis and its implications for cancer therapy
Dize Zhang, Yihang Qi, Hiroyuki Inuzuka, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 9, pp. 107709-107709
Open Access | Times Cited: 5
Unraveling the role of C1GALT1 in abnormal glycosylation and colorectal cancer progression
Hong Tian, Jiali Yu, Xiaoli Chu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
GALNT5 promotes migration and invasion of pancreatic ductal adenocarcinoma cells by activating Erk signaling pathway
Yongjia Zheng, Yao Lu, Yuan Fang, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2025), pp. 130769-130769
Closed Access
Role of malate dehydrogenase 1 and isocitrate dehydrogenase 1 and their posttranslational modifications in diseases
Chunxia Shi, Yukun Wang, Jin Guo, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 754, pp. 151535-151535
Closed Access
M2 macrophages-derived exosomal MDH1 drives lung adenocarcinoma progression via the Hippo/YAP signaling
Jie Zhang, Jinpeng Liu, Zhuixing Liu, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155902-155902
Closed Access
GATAD2B O-GlcNAcylation Regulates Breast Cancer Stem-like Potential and Drug Resistance
Lê Minh Giang, Jessica Merzy, Emily M. Esquea, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 398-398
Open Access
O-GlcNAc-modified HOXA9 suppresses ferroptosis via promoting UBR5-mediated SIRT6 degradation in nasopharyngeal carcinoma
H.J. Liu, Yaw‐Syan Fu, Ling Tang, et al.
Neoplasia (2025) Vol. 62, pp. 101142-101142
Closed Access
Page 1 - Next Page

Scroll to top